-
221
Tuning Triplet Exciton Pathways via Molecular Aggregation in a Family of Coordination Polymers
Published 2025“…Molecular aggregation is the key factor in determining the triplet exciton pathways of room-temperature phosphorescence (RTP) materials; however, controlling different aggregation forms and understanding their synergistic effects remain challenging. …”
-
222
Tuning Triplet Exciton Pathways via Molecular Aggregation in a Family of Coordination Polymers
Published 2025“…Molecular aggregation is the key factor in determining the triplet exciton pathways of room-temperature phosphorescence (RTP) materials; however, controlling different aggregation forms and understanding their synergistic effects remain challenging. …”
-
223
Tuning Triplet Exciton Pathways via Molecular Aggregation in a Family of Coordination Polymers
Published 2025“…Molecular aggregation is the key factor in determining the triplet exciton pathways of room-temperature phosphorescence (RTP) materials; however, controlling different aggregation forms and understanding their synergistic effects remain challenging. …”
-
224
Tuning Triplet Exciton Pathways via Molecular Aggregation in a Family of Coordination Polymers
Published 2025“…Molecular aggregation is the key factor in determining the triplet exciton pathways of room-temperature phosphorescence (RTP) materials; however, controlling different aggregation forms and understanding their synergistic effects remain challenging. …”
-
225
Tuning Triplet Exciton Pathways via Molecular Aggregation in a Family of Coordination Polymers
Published 2025“…Molecular aggregation is the key factor in determining the triplet exciton pathways of room-temperature phosphorescence (RTP) materials; however, controlling different aggregation forms and understanding their synergistic effects remain challenging. …”
-
226
-
227
Table 1_The evolving landscape of restrictive cardiomyopathy treatment: clinical trial trends and future directions.xlsx
Published 2025“…<p>Restrictive cardiomyopathy (RCM) is a rare form of heart muscle disease characterized predominantly by diastolic dysfunction and restrictive filling, for which no guideline-supported pharmacological treatment currently exists. …”
-
228
-
229
Oxidation of Alcohols to Carboxylates with N<sub>2</sub>O Catalyzed by Ruthenium(II)-CNC Complexes
Published 2025Subjects: -
230
Oxidation of Alcohols to Carboxylates with N<sub>2</sub>O Catalyzed by Ruthenium(II)-CNC Complexes
Published 2025Subjects: -
231
Impact of charged residues in a hexapeptide sequence on zipper propensity scores.
Published 2025Subjects: -
232
-
233
-
234
-
235
-
236
-
237
-
238
Average zipper propensity score as calculated by Rosetta from 1,563 proline-containing segments.
Published 2025Subjects: -
239
Impact of individual amino acid counts on predicted amyloid propensity scores in hexapeptides.
Published 2025Subjects: -
240